The U.S. Food and Drug Administration (FDA) has approved the first-ever oral pill for weight loss, marking a major milestone in medical treatment for obesity.
The pill, a version of the drug Wegovy made by Novo Nordisk, offers a needle-free alternative to the popular injectable treatments currently on the market.
Clinical trials have shown that taking one pill daily can lead to an average weight loss of around 16%, comparable to the results seen with injections.
The manufacturer states that this oral option will be a game-changer for patients who are uncomfortable with needles or prefer a more convenient method for managing their weight.
Set to hit the U.S. market in early 2026, the pill is expected to see high demand. Health experts believe this innovation could significantly impact global obesity rates by making effective treatment more accessible and easier to adhere to for millions of people.
Cloudflare